WallStreetZenWallStreetZen

NASDAQ: ABUS
Arbutus Biopharma Corp Stock Ownership - Who owns Arbutus Biopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arbutus Biopharma Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David C. HastingsChief Financial Officer2025-02-0422,183$3.28
$72.83kSell
Michael J. McElhaughInterim President CEO2025-02-0423,790$3.28
$78.10kSell
J. Christopher NaftzgerGeneral Counsel and CCO2025-02-0411,333$3.28
$37.21kSell
Karen SimsChief Medical Officer2025-02-0419,348$3.28
$63.52kSell

1 of 1

ABUS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ABUS insiders and whales buy or sell their stock.

ABUS Shareholders

What type of owners hold Arbutus Biopharma Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Roivant Sciences Ltd20.20%38,847,462$186.08MInsider
Matthew Gline20.20%38,847,462$186.08MInsider
Dexxon Holdings Ltd16.65%32,027,080$153.41MInsider
Morgan Stanley12.71%24,450,612$117.12MInstitution
Vivek Ramaswamy8.35%16,068,455$76.97MInsider
Rose Sharon Shabet8.33%16,013,540$76.70MInsider
Viking Global Performance LLC8.33%16,013,540$76.70MInsider
Viking Global Investors LP8.33%16,013,540$76.70MInsider
Viking Global Equities Master Ltd8.33%16,013,540$76.70MInsider
Svf Investments Uk Ltd8.33%16,013,540$76.70MInsider

1 of 3

ABUS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABUS29.82%70.18%Net Selling
BCAX70.36%29.64%Net SellingNet Buying
MDXG46.43%53.57%Net BuyingNet Selling
TBPH52.91%47.09%Net SellingNet Selling
ELVN49.49%50.51%Net SellingNet Selling
View Top Biotech Stocks

Arbutus Biopharma Stock Ownership FAQ

Who owns Arbutus Biopharma?

Arbutus Biopharma (NASDAQ: ABUS) is owned by 61.44% institutional shareholders, 144.61% Arbutus Biopharma insiders, and 0.00% retail investors. Roivant Sciences Ltd is the largest individual Arbutus Biopharma shareholder, owning 38.85M shares representing 20.20% of the company. Roivant Sciences Ltd's Arbutus Biopharma shares are currently valued at $189.58M.

If you're new to stock investing, here's how to buy Arbutus Biopharma stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.